tiprankstipranks
Adhera Therapeutics (ATRX)
OTHER OTC:ATRX
US Market

Adhera Therapeutics (ATRX) Financial Statements

13 Followers

Adhera Therapeutics Financial Overview

Adhera Therapeutics's market cap is currently $722.00. The company's EPS TTM is $-0.5392; its P/E ratio is ―; Adhera Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 21Dec 20Dec 19Dec 18
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 252.00K$ 76.19K
Gross Profit$ 0.00$ 0.00$ 0.00$ -157.00K$ -383.00K
Operating Income$ -1.62M$ -674.00K$ -2.04M$ -11.32M$ -15.79M
EBITDA$ -1.62M$ -674.00K$ -1.59M$ -11.23M$ -16.27M
Net Income$ -2.11M$ -6.35M$ -3.77M$ -11.98M$ -16.75M
Balance Sheet
Cash & Short-Term Investments$ 32.00K$ 76.00K$ 1.00K$ 50.00K$ 3.92M
Total Assets$ 79.00K$ 196.00K$ 1.00K$ 420.00K$ 5.14M
Total Debt$ 8.59M$ 6.66M$ 6.32M$ 5.33M$ 0.00
Net Debt$ 8.55M$ 6.59M$ 6.32M$ 5.28M$ -3.92M
Total Liabilities$ 22.27M$ 25.30M$ 14.77M$ 10.31M$ 2.21M
Stockholders' Equity$ -22.19M$ -25.11M$ -14.77M$ -9.89M$ 2.93M
Cash Flow
Free Cash Flow$ -1.42M$ -665.00K$ -588.00K$ -8.74M$ -9.69M
Operating Cash Flow$ -1.42M$ -665.00K$ -588.00K$ -8.74M$ -9.61M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ -74.36K
Financing Cash Flow$ 1.37M$ 739.00K$ 539.00K$ 4.87M$ 13.50M
Currency in USD

Adhera Therapeutics Earnings and Revenue History

Adhera Therapeutics Debt to Assets

Adhera Therapeutics Cash Flow

Adhera Therapeutics Forecast EPS vs Actual EPS